This review provides an overview of novel developments in catheter ablation technologies for atrial fibrillation and ventricular tachycardia in structurally abnormal hearts.
Answers are grounded in this paper and cite their sources.
May inform ablation strategies in complex AF/VT; leaves open prospective validation of novel technologies in structurally abnormal hearts.
Catheter ablation is an established treatment strategy for a range of different cardiac arrhythmias. Over the past decade two major areas of expansion have been ablation of atrial fibrillation (AF) and ventricular tachycardia (VT) in the context of structurally abnormal hearts. In parallel with the expanding role of catheter ablation for AF and VT, multiple novel technologies have been developed which aim to increase safety and procedural success. Areas of development include novel catheter designs, novel navigation technologies and higher resolution imaging techniques. The aim of the present review is to provide an overview of novel developments in AF ablation and VT ablation in patients with of structural cardiac diseases.
No takes yet. Share an insight, caveat, or question.
Mahida et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: